Why Cleveland-Cliffs Stock Is Red-Hot Today
Cleveland-Cliffs reported smaller-than-expected losses this morning.
Steel prices fell in Q2, but management is cutting costs to mitigate the damage.
With a little help from President Trump's tariffs, Cleveland-Cliffs could turn profitable again.
10 stocks we like better than Cleveland-Cliffs ›
Shares of Cleveland-Cliffs (NYSE: CLF), one of the nation's biggest steelmakers, soared 13.7% through 1:20 p.m. ET Monday after beating on earnings this morning.
Analysts had forecast a rough quarter for Cleveland-Cliffs, with $0.63 per share in losses expected on sales of $4.9 billion. The company nailed the revenue target, and beat on earnings with a loss of "only" $0.50 per share.
Cleveland-Cliffs' Q2 earnings
Cleveland-Cliffs set a new record for steel shipped in the quarter: 4.3 million net tons, up 7.5% from a year ago. Average selling prices on that steel, however, slid 10%, turning what should have been a revenue improvement into a decline -- and turning its gross profit margin negative.
On the bottom line, Cleveland-Cliffs ended up with $470 million in net losses, or $0.97 per share, reversing the tiny profit it earned in Q2 2024.
Is Cleveland-Cliffs stock a buy?
But if Cleveland-Cliff's news was so bad, why are investors buying the stock? Partly because management said $323 million of its net loss -- about 69% -- came from "previously disclosed non-recurring charges related to idled facilities." And partly, because management says it's making progress cutting both costs and inventories.
Turning to guidance, Cleveland-Cliffs notes that it's on track to cut its 2025 cost of production by about $50 a ton in comparison to 2024 -- enough to offset about half the decline in steel prices seen in Q2. Combined with reductions in capital spending and in selling, general, and administrative expenses, plus the absence of the "non-recurring charges" that hurt Q2 results, and of course the benefits Cleveland-Cliffs might enjoy from Trump administration tariffs on imported steel, there's every chance profits will perk back up soon.
Management didn't quite promise this, mind you. But investors seem to be betting on it.
Should you buy stock in Cleveland-Cliffs right now?
Before you buy stock in Cleveland-Cliffs, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Cleveland-Cliffs wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 21, 2025
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Why Cleveland-Cliffs Stock Is Red-Hot Today was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity
Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% growth on a YoY basis. The company reported GAAP diluted earnings per share of $1.01, while adjusted diluted EPS came in at $1.26. Gross margin was 52.7% of sales on a reported basis, with the adjusted gross margin reaching 57.0%, representing a 100 basis point improvement. Abbott Laboratories (NYSE:ABT) reiterated its guidance and pointed to strong momentum in both its devices and nutrition segments as it moves into the second half of the year. A brief valuation analysis, based on a five-year free cash flow CAGR of 5.74%— calculated using 6% growth in operating cash flow and 2% growth in capital expenditures— suggests that the current share price of $120.51 offers promising return potential. On June 13, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. This was the company's 406th consecutive quarterly dividend. In addition, ABT has raised its payouts for 53 years in a row. The stock offers a quarterly dividend of 1.86%, as of July 25. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
22 minutes ago
- Yahoo
Why Oversold Lockheed Martin (LMT) Could Be a Defensive Dividend Powerhouse
Lockheed Martin Corporation (NYSE:LMT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. Two fighter jets in flight, highlighting the technology and experience of the companies combat aircraft. The company has long held a leading position in the US aerospace and defense sector. It supplies advanced technologies and services to the US Department of Defense, NASA, and various international government agencies. Its space division is one of the company's four key segments. For investors looking for a diversified and established aerospace company with ties to the growing space industry, Lockheed Martin may be a strong addition to their portfolio. Lockheed Martin Corporation (NYSE:LMT) maintained a strong cash position, reinforcing its appeal as a reliable dividend investment. In the most recent quarter, the company reported an operating cash flow of $201 million. It also returned $1.3 billion to investors through dividends and share repurchases. On June 26, Lockheed Martin Corporation (NYSE:LMT) declared a quarterly dividend of $3.30 per share, which was consistent with its previous dividend. The company has been rewarding shareholders with growing dividends for the past 22 years. The stock offers a dividend yield of 3.11%, as of July 25. While we acknowledge the potential of LMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
22 minutes ago
- Yahoo
Oversold but Not Overlooked: Why FactSet (FDS) Deserves a Second Look
FactSet Research Systems Inc. (NYSE:FDS) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An investment banker consulting with a customer on their portfolio in a professional setting. The company's third-quarter earnings demonstrated the successful implementation of its enterprise solution strategy. With a strong pipeline and growing momentum, it appeared well-positioned to close the fiscal year on a solid note. FactSet Research Systems Inc. (NYSE:FDS) reported revenue of $585.5 million in fiscal Q3 2025, up 6% from the same period last year. The revenue also beat analysts' estimates by $4.62 million. As of May 31, 2025, the company's Annual Subscription Value (ASV) reached $2.33 billion, an increase from $2.2 billion recorded on the same date in 2024. On an organic basis, ASV stood at $2.3 billion, reflecting a year-over-year growth of 4.5%, or $98.5 million. FactSet Research Systems Inc. (NYSE:FDS)'s cash position also remained strong. The company reported an operating cash flow of $253.8 million and its free cash flow was $228.6 million, both up by 6.5% and 5.4%, respectively. In addition, it returned $41.6 million to shareholders through dividends, which showed the commitment toward its investors. FactSet Research Systems Inc. (NYSE:FDS) currently offers a quarterly dividend of $1.10 per share, having raised it by 6% in May 2025. This was the company's 26th consecutive year of dividend growth. The stock has a dividend yield of 1.05%, as of July 25. While we acknowledge the potential of FDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
